152 related articles for article (PubMed ID: 263658)
1. Comparison of [125I]somatomedin A and [125I]somatomedin C radioreceptor assays for somatomedin peptide content in whole and acid-chromatographed plasma.
Horner JM; Liu F; Hintz RL
J Clin Endocrinol Metab; 1978 Dec; 47(6):1287-95. PubMed ID: 263658
[TBL] [Abstract][Full Text] [Related]
2. Further comparisons of the [125I]somatomedin A and the [125I]somatomedin C radioreceptor assays of somatomedin peptide.
Horner JM; Hintz RL
J Clin Endocrinol Metab; 1979 Jun; 48(6):959-63. PubMed ID: 447802
[TBL] [Abstract][Full Text] [Related]
3. Isolation of a somatomedin from plasma of rats bearing growth hormone secreting tumors.
Chochinov RH; Mariz IK; Daughaday WH
Endocrinology; 1977 Feb; 100(2):549-56. PubMed ID: 188631
[TBL] [Abstract][Full Text] [Related]
4. Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay.
Kemp SF; Rosenfeld RG; Liu F; Gaspich S; Hintz RL
J Clin Endocrinol Metab; 1981 Apr; 52(4):616-21. PubMed ID: 7204536
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a protein in mid-term human amniotic fluid which reacts in the somatomedin-C radioreceptor assay.
Chochinov RH; Mariz IK; Hajek AS; Daughaday WH
J Clin Endocrinol Metab; 1977 May; 44(5):902-8. PubMed ID: 870516
[TBL] [Abstract][Full Text] [Related]
6. Serum somatomedin levels in adults with chronic renal failure: the importance of measuring insulin-like growth factor I (IGF-I) and IGF-II in acid-chromatographed uremic serum.
Powell DR; Rosenfeld RG; Baker BK; Liu F; Hintz RL
J Clin Endocrinol Metab; 1986 Nov; 63(5):1186-92. PubMed ID: 3760118
[TBL] [Abstract][Full Text] [Related]
7. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma.
Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S
J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741
[TBL] [Abstract][Full Text] [Related]
8. Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins.
Svoboda ME; Van Wyk JJ; Klapper DG; Fellows RE; Grissom FE; Schlueter RJ
Biochemistry; 1980 Feb; 19(4):790-7. PubMed ID: 7188854
[TBL] [Abstract][Full Text] [Related]
9. Basic peptide with insulin-like activity in human serum.
Sasaki N; Okabe T; Imai Y; Matsuzaki F; Kosaka K; Wakai K; Tsushima T
Endocrinol Jpn; 1981 Apr; 28(2):157-67. PubMed ID: 7030722
[TBL] [Abstract][Full Text] [Related]
10. Isolation and partial characterization of six somatomedin-like peptides from human plasma Cohn fraction IV.
Blum WF; Ranke MB; Bierich JR
Acta Endocrinol (Copenh); 1986 Feb; 111(2):271-84. PubMed ID: 3953237
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma somatomedin reactivity in chronic renal failure as determined by acid gel filtration and radioreceptor assay.
Schiffrin A; Guyda H; Robitaille P; Posner B
J Clin Endocrinol Metab; 1978 Mar; 46(3):511-3. PubMed ID: 752037
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of type I and type II somatomedin receptors on bovine growth plate chondrocytes.
Trippel SB; Chernausek SD; Van Wyk JJ; Moses AC; Mankin HJ
J Orthop Res; 1988; 6(6):817-26. PubMed ID: 2971791
[TBL] [Abstract][Full Text] [Related]
13. Somatomedin binding proteins in GH-deficient children with normal plasma somatomedin levels.
Cohen DA; Blethen SL
J Clin Endocrinol Metab; 1983 Mar; 56(3):461-6. PubMed ID: 6185524
[TBL] [Abstract][Full Text] [Related]
14. Partial characterization of a somatomedin-like peptide from the medium of cultured rat Sertoli cells.
Smith EP; Svoboda ME; Van Wyk JJ; Kierszenbaum AL; Tres LL
Endocrinology; 1987 Jan; 120(1):186-93. PubMed ID: 2946573
[TBL] [Abstract][Full Text] [Related]
15. Somatomedin peptide distribution and somatomedin-binding protein content in cord plasma: comparison to normal and hypopituitary plasma.
Borsi L; Rosenfeld RG; Liu F; Hintz RL
J Clin Endocrinol Metab; 1982 Feb; 54(2):223-8. PubMed ID: 6172441
[TBL] [Abstract][Full Text] [Related]
16. Liberation of immunoreactive somatomedin-C from its binding proteins by proteolytic enzymes and heparin.
Clemmons DR; Underwood LE; Chatelain PG; Van Wyk JJ
J Clin Endocrinol Metab; 1983 Feb; 56(2):384-9. PubMed ID: 6185523
[TBL] [Abstract][Full Text] [Related]
17. Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.
Van Wyk JJ; Svoboda ME; Underwood LE
J Clin Endocrinol Metab; 1980 Jan; 50(1):206-8. PubMed ID: 7350184
[TBL] [Abstract][Full Text] [Related]
18. Fetal rat myoblasts release both rat somatomedin-C (SM-C)/insulin-like growth factor I (IGF I) and multiplication-stimulating activity in vitro: partial characterization and biological activity of myoblast-derived SM-C/IGF I.
Hill DJ; Crace CJ; Nissley SP; Morrell D; Holder AT; Milner RD
Endocrinology; 1985 Nov; 117(5):2061-72. PubMed ID: 4042975
[TBL] [Abstract][Full Text] [Related]
19. The binding of insulin and somatomedin A to human placental membrane.
Takano K; Hall K; Fryklund L; Holmgren A; Sievertsson H; Uthne K
Acta Endocrinol (Copenh); 1975 Sep; 80(1):14-31. PubMed ID: 1173978
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity.
Herington AC; Kuffer AD
Biochem J; 1984 Oct; 223(1):89-96. PubMed ID: 6388566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
